drugset / Trial / NCT02512523

Exploratory Study to Compare the Effects of Tenelia® or Januvia® on Glucose Variability in add-on to Metformin (CGMS Study)

NCT02512523

Phase 4 Completed 39 enrolled Handok Inc.
RandomizedParallel-groupQuadruple-blindTreatment

Summary

This is a randomized, double-blind, active control, parallel group, exploratory phase 4 study to compare the effect of teneligliptin versus sitagliptin on glucose variability when added on to metformin in patients with inadequately controlled type 2 diabetes mellitus.

Timeline

Start
2015-08-27
Primary completion
2016-09-26
Completion
2016-09-26

Drugs

EvaluationDrugModalityDoseRoute
Comparator Sitagliptin Small molecule 100 mg Oral
Subject Teneligliptin Small molecule 20 mg Oral